Go to the list of all blogs
Serhii Bondarenko's Avatar
published in Blogs
Nov 16, 2026
TickeronGET DAILY SIGNALS
Tradr 2X Long TEM Daily ETF (TEMT) Delivers +25% Over the Quarter Despite Volatility

Tradr 2X Long TEM Daily ETF (TEMT) Delivers +25% Over the Quarter Despite Volatility

Key Takeaways

  • TEMT is a single-stock leveraged ETF that seeks 200% (2x) of the daily return of Tempus AI common stock, before fees and expenses.
  • The fund holds a derivative (contract-for-difference, or CFD) position on Tempus AI plus cash collateral rather than a diversified basket, making it non-diversified and highly concentrated.
  • Over the trailing 30 days, TEMT was essentially flat (down roughly 1%), but the path was extremely volatile, with frequent double-digit daily swings.
  • Over the trailing quarter, the fund rose about 25%, reflecting a sharp rally in the underlying AI-healthcare stock followed by a meaningful pullback.
  • Daily reset mechanics introduce compounding, often called volatility decay, that can cause multi-day returns to diverge materially from 2x the underlying's cumulative move.
  • A 1.30% net expense ratio and modest assets under management (AUM) are notable cost and liquidity considerations for this product.
  • For additional detail on this fund's technical setup and valuation signals, explore Price Targets and Forecast pages.
  • Explore Trending AI Robots for automated strategy and screening ideas.

Overview of the Tradr 2X Long TEM Daily ETF (TEMT)

TEMT is an actively managed, leveraged single-stock ETF advised by AXS Investments under the Tradr brand. The fund seeks daily investment results, before fees and expenses, that correspond to two times (200%) the daily performance of the common shares of Tempus AI, a healthcare technology company that applies artificial intelligence and molecular data to precision medicine. The fund does not track a broad index; instead, it attempts to maintain at least 80% exposure to instruments that provide 2x daily leveraged exposure to the single underlying stock, rebalancing daily.

Because it is a derivative-based vehicle, the portfolio is small in the conventional sense. It holds a CFD on Tempus AI alongside cash used as collateral, rather than a basket of individual securities. The fund is classified as non-diversified and carries a net expense ratio of approximately 1.30%. Its AUM has generally remained modest, in the low tens of millions of dollars, which is a relevant consideration for liquidity and bid-ask spreads.

The Industry and Thematic Context

TEMT's entire return profile is concentrated in the AI-enabled healthcare and precision-medicine theme. Tempus AI operates at the intersection of genomics, clinical data, diagnostics, and artificial intelligence, a segment that has attracted substantial investor attention as healthcare organizations adopt data-driven tools for diagnosis and treatment selection. Companies in this space are typically early-stage or growth-oriented and frequently trade on forward revenue expectations rather than current profitability.

The broader backdrop matters disproportionately for this fund because leverage amplifies every move in the underlying. High-multiple growth equities remain sensitive to interest-rate expectations, inflation data, and overall risk appetite, while competitive developments in the artificial intelligence sector can trigger abrupt repricing. These conditions have produced a regime of elevated volatility for leveraged single-stock products, with large daily moves in both directions. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Recent Performance and Positioning

Over the trailing 30 days, TEMT was roughly flat, edging down approximately 1% from the mid-October closing level near $23 to a recent price near $23. That modest net change obscures an exceptionally volatile path, with routine daily moves in the double digits reflecting twice the underlying stock's swings.

The trailing-quarter picture is more constructive on a net basis: the fund rose approximately 25% from the mid-August level near $18. That advance was not smooth. The fund rallied strongly into late September, pulled back sharply, and then recovered partially, underscoring how leveraged single-stock exposure converts a trending underlying into a high-amplitude, range-prone price series. For investors, the key structural point is that the fund's objective is a daily multiple, so returns held beyond a single session are shaped by the compounding of daily resets rather than by a simple 2x of the cumulative move.

2026 Outlook and Key Factors to Monitor

The most important structural factor for TEMT in 2026 is the fundamental trajectory of its single underlying holding. Tempus AI's revenue growth, commercial adoption of its data and diagnostics offerings, and progress toward profitability will remain the dominant drivers of the fund's performance, amplified by the 2x daily leverage.

Macroeconomic conditions will also matter. Interest-rate policy, inflation trends, and overall investor appetite for high-multiple growth equities can influence how aggressively the underlying stock is revalued. Competitive and regulatory developments in AI-driven healthcare, including data privacy considerations, could introduce additional volatility. Finally, investors should account for the vehicle's own structural characteristics: daily reset decay, the 1.30% expense ratio, financing costs embedded in derivative exposure, and the fund's small size, which can affect spreads and liquidity. These factors make TEMT a tactical, short-horizon instrument rather than a buy-and-hold vehicle, and they should be monitored alongside any fundamental view on the underlying company.

Exploring AI-Powered Research Tools

In my own process, I frequently turn to Tickeron’s AI Screener when evaluating concentrated or leveraged products like TEMT. It helps surface momentum, volatility, and sector comparisons across thousands of securities using technical indicators, fundamentals, and AI signals, allowing for more efficient identification of opportunities that align with a particular research focus.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: TEMT

Contributor

Serhii Bondarenko is an AI-focused trading strategist and financial markets analyst specializing in the development and application of AI trading bots and autonomous trading agents. His work combines technical analysis, fundamental analysis, and quantitative research to identify market patterns, forecast price movements, and analyze liquidity, volatility, and correlations across global stock markets. Serhii actively publishes market insights, forecasts, and trading frameworks on platforms such as Investing.com and Finextra, with a strong focus on AI-driven decision-making and next-generation algorithmic trading. His research aims to bridge the gap between traditional trading methodologies and advanced artificial intelligence, helping traders and investors navigate complex and rapidly evolving market conditions.


TEMT in upward trend: 10-day moving average crossed above 50-day moving average on November 06, 2026

The 10-day moving average for TEMT crossed bullishly above the 50-day moving average on November 06, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 4 of 4 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a +41.82% 3-day Advance, the price is estimated to grow further. Considering data from situations where TEMT advanced for three days, in 76 of 80 cases, the price rose further within the following month. The odds of a continued upward trend are 90%.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 15 of 16 cases where TEMT's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 90%.

The Momentum Indicator moved below the 0 level on November 12, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on TEMT as a result. In 22 of 22 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.

The Moving Average Convergence Divergence Histogram (MACD) for TEMT turned negative on November 13, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 12 similar instances when the indicator turned negative. In 12 of the 12 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.

TEMT moved below its 50-day moving average on November 12, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TEMT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

TEMT broke above its upper Bollinger Band on October 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for TEMT entered a downward trend on November 02, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Industry description

The investment seeks daily investment results, before fees and expenses, that correspond to two times (200%) the daily performance of the common shares of TEM. Under normal market circumstances, the fund will maintain at least 80% exposure to financial instruments that provide two times leveraged exposure to the daily performance of TEM. The Advisor attempts to consistently apply leverage to increase the fund’s exposure to 200% of TEM, and expects to rebalance the fund’s holdings daily to maintain such exposure. The fund is non-diversified.
AI Screener 3
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
Interact to see
Advertisement
NVIDIA shares declined roughly 26% over the 30 days ending mid-November, falling from a close near $221 to $162.85. The drop left the stock about 30% below its October 6 record intraday high of $243.37 and at a 52-week low.
ACHR fell -7.44% in Monday's regular session, sliding from Friday's $4.03 close to $3.73 shortly after 10 a.m. ET — a third consecutive daily decline that pushed shares back toward their November 5 low. No verified news or fundamental catalyst found for today's leg lower; the selling extends the de-rating that followed Q3 results — revenue of just $5.1 million, a net loss widening 111% to $274.6 million, and price-target cuts from Cantor Fitzgerald, Needham and Canaccord.
Micron shares fell -6.28% to $729.40 from Friday's $778.31 close, gapping lower in premarket trading and holding those losses into Monday's regular session. The decline was sector-driven, not company-specific: memory peers SanDisk, SK hynix and Western Digital slid in tandem as last week's Nvidia CEO departure revived doubts over AI data-center spending, financing and memory demand durability.
Dell Technologies (DELL) fell roughly 23.7% over the last 30 days, sliding from a closing price of $451.71 on October 16, 2026, to $344.53 on November 13, 2026. The decline accelerated after the U.S. midterm elections, when investor concerns about potential AI and data-center regulation triggered a sharp sell-off across AI hardware names.
LITE is the Nasdaq-listed ticker for Lumentum Holdings Inc., a global manufacturer of optical and photonic products used in data centers, AI infrastructure, and telecommunications networks. The company was spun off from JDS Uniphase and incorporated in 2015, with headquarters in San Jose, California.